Back to discover

Protein / target

Growth factor receptor-bound protein 10

Encoded byGRB10Q13322Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
High-Quality Pocket
1
Research papers

Protein at a glance

Biological role

Signaling receptor complex adaptor

Strongest disease association

Diabetes Mellitus, Type 2

Via encoding gene GRB10 · Genetic evidence · score 0.69

Research activity

Emerging research

1 papers · latest 2013

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Adapter protein which modulates coupling of a number of cell surface receptor kinases with specific signaling pathways.

View complete UniProt function annotation

Adapter protein which modulates coupling of a number of cell surface receptor kinases with specific signaling pathways. Binds to, and suppress signals from, activated receptors tyrosine kinases, including the insulin (INSR) and insulin-like growth factor (IGF1R) receptors. The inhibitory effect can be achieved by 2 mechanisms: interference with the signaling pathway and increased receptor degradation. Delays and reduces AKT1 phosphorylation in response to insulin stimulation. Blocks association between INSR and IRS1 and IRS2 and prevents insulin-stimulated IRS1 and IRS2 tyrosine phosphorylation. Recruits NEDD4 to IGF1R, leading to IGF1R ubiquitination, increased internalization and degradation by both the proteasomal and lysosomal pathways. May play a role in mediating insulin-stimulated ubiquitination of INSR, leading to proteasomal degradation. Negatively regulates Wnt signaling by interacting with LRP6 intracellular portion and interfering with the binding of AXIN1 to LRP6. Positive regulator of the KDR/VEGFR-2 signaling pathway. May inhibit NEDD4-mediated degradation of KDR/VEGFR-2

Subcellular location

Cytoplasm
Domains and Gene Ontology detail (20)

Domains & features

Ras-associatingPHSH2

Gene Ontology

  • Ccytoplasm
  • Ccytosol
  • Cplasma membrane
  • Cprotein-containing complex
  • Fidentical protein binding
  • Finsulin receptor binding
  • Fsignaling receptor complex adaptor activity
  • Pinsulin receptor signaling pathway
  • Pintracellular signal transduction
  • Pnegative regulation of D-glucose import across plasma membrane
  • Pnegative regulation of glycogen biosynthetic process
  • Pnegative regulation of insulin receptor signaling pathway

594 aa · 67 kDa · 4 isoforms

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Growth-factor signallingUniProt · GO
View supporting evidence

Growth-factor signalling

  • ·Adapter protein which modulates coupling of a number of cell surface receptor kinases wi…
  • ·positive regulation of vascular endothelial growth factor receptor signaling pathway

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene GRB10

Gene-level evidence surfaced through the gene GRB10 that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Diabetes Mellitus, Type 2
0.72Moderately supported

Genetic evidence dominant · Open Targets 0.44

Presbycusis
0.67Moderately supported

Genetic evidence dominant · Open Targets 0.40

Atrial Fibrillation
0.64Moderately supported

Genetic evidence dominant · Open Targets 0.39

Gout
0.59Moderately supported

Genetic evidence dominant · Open Targets 0.36

Carcinoma, Renal Cell
0.57Moderately supported

Genetic evidence dominant · Open Targets 0.35

View evidence synthesis (5)
Diabetes Mellitus, Type 2Moderately supported
0.72
agreement 0.580.86
Genetic90%Literature10%

Open Targets aggregate 0.44 · 2 independent evidence families

PresbycusisModerately supported
0.67
agreement 0.550.79
Genetic100%

Open Targets aggregate 0.40 · 1 independent evidence family

Atrial FibrillationModerately supported
0.64
agreement 0.520.76
Genetic100%

Open Targets aggregate 0.39 · 1 independent evidence family

GoutModerately supported
0.59
agreement 0.470.71
Genetic100%

Open Targets aggregate 0.36 · 1 independent evidence family

Carcinoma, Renal CellModerately supported
0.57
agreement 0.430.71
Genetic99%Literature1%

Open Targets aggregate 0.35 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Neurodegenerative Diseases0.54
Diabetes Mellitus, Type 20.44
Presbycusis0.40
Atrial Fibrillation0.39
Gout0.36
Carcinoma, Renal Cell0.35
Prostate carcinoma0.29
Diabetes Mellitus, Type 10.28

Tractability

Small moleculesEmerging

Feasibility evidence (high-quality pocket) — no clinical-stage drug of this modality recorded.

AntibodiesEmerging

Feasibility evidence (go cc high conf) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (database ubiquitination and half-life data) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (4)
SM · High-Quality PocketAB · GO CC high confPR · Database UbiquitinationPR · Half-life Data

Raw Open Targets tractability assessment buckets, by modality.

Research activity

1 papers · to 2013

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Recent

Europe PMC papers linked directly to this protein.